COVID-19 has displayed heterogeneity in the clinical manifestations ranging from asymptomatic state to life treating severe acute respiratory distress syndrome. Gustatory impairment (45%) in the form of dysgeusia (38%), hypogeusia (35%) and ageusia (24%) are the most common manifestation followed by the mucosal erythema or ulcerations [1]. Apart from these two, literature also reported anosmia as one of the most common manifestations of COVID-19 [2]. Majority of the patients showed only gustatory and olfactory manifestations without any evidence of respiratory symptoms [2]. Many hypotheses have been proposed to envisage oral manifestations seen in COVID-19 patients but none has been tested and proved with appropriate scientific experimentations. A brief overview of proposed pathogenesis is reflected in Table 1 [4], [5], [6], [7]. In the present letter, we proposed a novel hypothesis that links the SARS-CoV-2 with anemia and oral manifestations.
Table 1.
Proposed hypotheses for the oral manifestations in COVID-19 patients.
| Authors | Year | Pathology | Proposed Hypothesis |
|---|---|---|---|
| Finsterer and Stollberger [3] | 2020 | Gustatory manifestations | Local inflammatory response resulting from rhinitis hampers the normal function of taste buds. |
| Finsterer and Stollberger [3] | 2020 | Gustatory manifestations | Direct interaction of SARS-CoV-2 with gustatory components and ACE2 receptors. |
| Vaira, Salzano, Fois, et al. [4] | 2020 | Gustatory manifestations | SARS-CoV-2 may bind essential salivary mucin components, such as sialic acid, consequently accelerating taste particle degradation and disturbing gustatory sensation |
| Nataf [5] | 2020 | Gustatory manifestations | ACE2 interaction with SARSCoV-2 may affect normal gustatory functions through dopamine and serotonin synthesis pathway co-regulation. |
| Mariz et al. [6] | 2020 | Gustatory manifestations | Inability of ACE2 to degrade Angiotensin II protein during COVID-19 infection, resulting in disorderly taste responses. |
| Galván Casas et al. [7] | 2020 | Mucosal ulcers | Not a primary manifestation of SARSCoV-2 but secondary manifestation related to co-infections from bacterial and viruses |
| Current hypothesis | 2020 | Gustatory manifestations and mucosal ulcers | Anemia related to SARS-CoV-2 mediated hemolysis causes the oral manifestations. |
Hypothesis: Anemia related to SARS-CoV-2 mediated hemolysis causes the oral manifestations.
ACE2, CD147, and CD26 receptors present on the erythrocytes are potential targets for SARS-CoV-2 attachment, which can lead to hemolysis [8]. Moreover, SARS-CoV-2 may mimic the action of hepcidin, which increases circulating and tissue ferritin leading to serum iron deficiency and anemia [8]. In support of this contention, significantly higher number of COVID-19 patients demonstrated severe anemia and hyperferritenemia [9], [10].
Intriguingly, gustatory impairment and mucosal ulcerations including anosmia are the prime manifestations of iron deficiency anemia [11]. These manifestations are results of the impaired oxygen supply and related cellular atrophy in the taste buds, oral epithelium and olfactory epithelium. Thus, we strongly believe that pathogenesis for oral manifestations seen in COVID-19 could be related to SARS-CoV-2 induced anemia. Burning sensation of oral cavity, canker sores and pale oral mucosa are other manifestations associated with iron deficiency anemia and they should also be investigated in COVID-19 patients. We believe that they could be missed out due to mild nature of these symptoms or unawareness among the healthcare workers.
To prove the proposition, a correlative study of total iron binding capacity or hemoglobin level and oral manifestations is warranted in COVID-19 patients. If this proposition holds true then it will help in effective management of oral health of COVID-19 patients.
Funding source
The author received no specific funding for this work.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
- 1.Amorim Dos Santos J., Normando A.G.C., Carvalho da Silva R.L., Acevedo A.C., De Luca C.G., Sugaya N. Oral manifestations in patients with COVID-19: a living systematic review. J Dent Res. 2020;11 doi: 10.1177/0022034520957289. 22034520957289. [DOI] [PubMed] [Google Scholar]
- 2.Vaira L.A., Salzano G., Deiana G., De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;130(7):1787. doi: 10.1002/lary.28692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Finsterer J., Stollberger C. Causes of hypogeusia/hyposmia in SARS‐CoV2 infected patients. J Med Virol. 2020;92(10):1793–1794. doi: 10.1002/jmv.25903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Vaira L.A., Salzano G., Fois A.G., Piombino P., De Riu G. Potential pathogenesis of ageusia and anosmia in COVID‐19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103–1104. doi: 10.1002/alr.22593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Nataf S. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID‐19. J Med Virol. 2020;92(10):1743–1744. doi: 10.1002/jmv.25826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mariz B.A.L.A., Brandão T.B., Ribeiro A.C.P., Lopes M.A., Santos-Silva A.R. New insights for the pathogenesis of COVID-19-related dysgeusia. J Dent Res. 2020;99(10) doi: 10.1177/0022034520936638. 1206–1206. [DOI] [PubMed] [Google Scholar]
- 7.Galván Casas C., Català A., Carretero Hernández G., Rodríguez-Jiménez P., Fernández-Nieto D., Rodríguez-Villa Lario A., Navarro Fernández I., Ruiz-Villaverde R., Falkenhain-López D., Llamas Velasco M. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–77. doi: 10.1111/bjd.19163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cavezzi A., Troiani E., Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020;10(2):1271. doi: 10.4081/cp.2020.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 26;368:m1091. [DOI] [PMC free article] [PubMed]
- 10.Richardson S., Hirsch J.S., Narasimhan M. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dinc M.E., Dalgic A., Ulusoy S., Dizdar D., Develioglu O., Topak M. Does iron deficiency anemia affect olfactory function? Acta Otolaryngol. 2016;136(7):754–757. doi: 10.3109/00016489.2016.1146410. [DOI] [PubMed] [Google Scholar]